KDOQI CLINICAL PRACTICE GUIDELINE FOR VASCULAR ACCESS: 2019 UPDATE

被引:1221
|
作者
Lok, Charmaine E. [1 ,2 ,3 ]
Huber, Thomas S. [4 ]
Lee, Timmy [5 ,6 ]
Shenoy, Surendra [7 ,8 ]
Yevzlin, Alexander S. [9 ,10 ]
Abreo, Kenneth [11 ,12 ]
Allon, Michael [13 ,14 ]
Asif, Arif [15 ]
Astor, Brad C. [16 ,17 ]
Glickman, Marc H. [18 ]
Graham, Janet [19 ,20 ]
Moist, Louise M. [21 ]
Rajan, Dheeraj K. [22 ,23 ]
Roberts, Cynthia [24 ]
Vachharajani, Tushar J. [25 ,26 ,27 ]
Valentini, Rudolph P. [28 ]
机构
[1] Univ Toronto, Med, Toronto, ON, Canada
[2] Univ Hlth Network, Multicare Kidney Clin & Hemodialysis Program, Toronto, ON, Canada
[3] Toronto Gen Res Inst, Toronto, ON, Canada
[4] Univ Florida, Coll Med, Div Vasc Surg, Surg & Chief, Gainesville, FL USA
[5] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA
[6] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA
[7] Washington Univ, Surg, St Louis, MO 14263 USA
[8] Washington Univ, Living Donor Transplantat Program, St Louis, MO 14263 USA
[9] Univ Michigan, Med, Ann Arbor, MI 48109 USA
[10] Univ Michigan, Intervent Nephrol, Ann Arbor, MI 48109 USA
[11] LSU Hlth Shreveport Sch Med, Div Nephrol, Shreveport, LA USA
[12] LSU Hlth Shreveport Sch Med, Dept Med, Shreveport, LA USA
[13] Univ Alabama Birmingham, Clin Affairs, Div Nephrol, Birmingham, AL USA
[14] Univ Alabama Birmingham, Dialysis Operat, Div Nephrol, Birmingham, AL USA
[15] Seton Hall Hackensack Meridian Sch Hlth, Jersey Shore Med Ctr, Neptune, NJ USA
[16] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA
[17] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53706 USA
[18] Hancock Jaffe Labs, Irvine, CA USA
[19] Ottawa Hosp, Nephrol, Ottawa, ON, Canada
[20] Champlain LHIN Ontario Renal Network, Nephrol, Toronto, ON, Canada
[21] Western Univ, Div Nephrol, London, ON, Canada
[22] Univ Toronto, Radiol, Toronto, ON, Canada
[23] Univ Toronto, Vasc & Intervent Radiol, Toronto, ON, Canada
[24] Univ N Carolina, Renal Res Inst, Nephrol & Hypertens Div, Chapel Hill, NC 27515 USA
[25] Case Western Reserve Univ, Med, Cleveland Clin, Coll Med, Cleveland, OH 44106 USA
[26] Cleveland Clin, Intervent Nephrol, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[27] Cleveland Clin, Global Nephrol, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[28] Wayne State Univ, Sch Med, Childrens Hosp Michigan, Detroit, MI 48202 USA
基金
美国国家卫生研究院;
关键词
TUNNELED HEMODIALYSIS CATHETERS; CENTRAL VENOUS CATHETER; ARTERIOVENOUS-FISTULA CREATION; RANDOMIZED CONTROLLED-TRIAL; BLOOD-STREAM INFECTIONS; CEPHALIC ARCH STENOSIS; STAGE RENAL-DISEASE; INSERTED CENTRAL CATHETERS; CHRONIC KIDNEY-DISEASE; JUXTA-ANASTOMOTIC STENOSIS;
D O I
10.1053/j.ajkd.2019.12.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for hemodialysis vascular access since 1996. Since the last update in 2006, there has been a great accumulation of new evidence and sophistication in the guidelines process. The 2019 update to the KDOQI Clinical Practice Guideline for Vascular Access is a comprehensive document intended to assist multidisciplinary practitioners care for chronic kidney disease patients and their vascular access. New topics include the end-stage kidney disease "Life-Plan" and related concepts, guidance on vascular access choice, new targets for arteriovenous access (fistulas and grafts) and central venous catheters, management of specific complications, and renewed approaches to some older topics. Appraisal of the quality of the evidence was independently conducted by using a Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, and interpretation and application followed the GRADE Evidence to Decision frameworks. As applicable, each guideline statement is accompanied by rationale/background information, a detailed justification, monitoring and evaluation guidance, implementation considerations, special discussions, and recommendations for future research.
引用
收藏
页码:S1 / S164
页数:164
相关论文
共 50 条
  • [1] KDOQI Clinical Practice Guideline for Vascular Access 2019 Update: Kinder, Gentler, and More Important Than Ever
    Trerotola, Scott O.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 31 (07) : 1156 - 1157
  • [3] KDOQI CLINICAL PRACTICE GUIDELINE FOR HEMODIALYSIS ADEQUACY: 2015 UPDATE
    Daugirdas, John T.
    Depner, Thomas A.
    Inrig, Jula
    Mehrotra, Rajnish
    Rocco, Michael V.
    Suri, Rita S.
    Weiner, Daniel E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (05) : 884 - 930
  • [4] KDOQI CLINICAL PRACTICE GUIDELINE FOR NUTRITION IN CKD: 2020 UPDATE
    Ikizler, T. Alp
    Burrowes, Jerrilynn D.
    Byham-Gray, Laura D.
    Campbell, Katrina L.
    Carrero, Juan-Jesus
    Chan, Winnie
    Fouque, Denis
    Friedman, Allon N.
    Ghaddar, Sana
    Goldstein-Fuchs, D. Jordi
    Kaysen, George A.
    Kopple, Joel D.
    Teta, Daniel
    Wang, Angela Yee-Moon
    Cuppari, Lilian
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (03) : S11 - +
  • [5] KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update Foreword
    Rocco, Michael V.
    Berns, Jeffrey S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 60 (05) : 857 - 857
  • [8] Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease
    Lambert, Kelly
    Bahceci, Su
    Harrison, Harriet
    Chan, Maria
    Scholes-Robertson, Nicole
    Johnson, David W.
    Yip, Adela
    Viecelli, Andrea K.
    NEPHROLOGY, 2022, 27 (06) : 537 - 540
  • [9] KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD
    Mottl, Amy K.
    Nicholas, Susanne B.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (03) : 277 - 287
  • [10] KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target
    Levin, Adeera
    Rocco, Michael
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (03) : 471 - 530